PD-L1 ADC肺癌数据积极 复宏汉霖HLX43迎关键节点与资金考验

每日经济新闻
Nov 05

在近日举行的“2025国际肺癌前沿及创新论坛”上,复宏汉霖更新了HLX43在非小细胞肺癌(NSCLC)研究领域的关键数据。  研究数据显示,不论是在鳞状还是非鳞状NSCLC,无论EGFR突变状态、是否伴有脑转移或PD-L1表达水平如何,HLX43均观察到疗效信号。复宏汉霖执行董事兼CEO朱俊在接受《每日经济新闻》记者采访时表示,“这些数据为Ⅱ期和Ⅲ期临床试验的剂量选择提供了关键依据,为后续开展...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10